Jenburkt和NINHANS团队通过远程医疗讲座提高医生对神经病的认识。 Jenburkt and NIMHANS team up to boost neuropathy awareness among doctors via telemedicine lectures.

Jenburkt制药公司和印度NINHANS研究所发起了伙伴关系,以提高对神经病的认识和诊断。 Jenburkt Pharmaceuticals and India's NIMHANS institute have launched a partnership to improve neuropathy awareness and diagnosis. 通过远程医疗系列讲座,他们旨在教育医疗专业人员认识神经损伤的早期迹象,神经损伤往往得不到诊断,并可能导致慢性疼痛和并发症。 Through a telemedicine lecture series, they aim to educate medical professionals on recognizing early signs of nerve damage, which often goes undiagnosed and can lead to chronic pain and complications. 该倡议力求改变病人的结果,将神经病带入保健优先事项的最前沿。 The initiative seeks to transform patient outcomes and bring neuropathy to the forefront of healthcare priorities.